122 related articles for article (PubMed ID: 3929276)
1. Enhanced prostacyclin biosynthesis and decreased thromboxane formation by 3-dimethylamino 5-(2',6'-dichlorobenzylidene) 6-methyl (4H)-pyridazine (PC 89).
Pham HC; Lasserre B; Tronche P; Couquelet J; Dossou-Gbete V; Palhares de Miranda AL
Prostaglandins Leukot Med; 1985 Jul; 19(1):37-49. PubMed ID: 3929276
[TBL] [Abstract][Full Text] [Related]
2. An inhibitor of prostacyclin biosynthesis derived from aminopyridazine.
Chanh PH; Lasserre B; Dossou-Gbete V; Couquelet J; Tronche P
Prostaglandins Leukot Med; 1987 Nov; 30(1):1-7. PubMed ID: 3124135
[TBL] [Abstract][Full Text] [Related]
3. A selective inhibitor of thromboxane synthetase activity of rabbit heart tissue: a pyridazinic derivative.
Pham Huu Chanh ; Lasserre B; Pham Huu Chanh A; Palhares de Miranda AL; Tronche P; Couquelet J; Rubat C
Prostaglandins Leukot Essent Fatty Acids; 1988 Aug; 33(2):143-7. PubMed ID: 3140251
[TBL] [Abstract][Full Text] [Related]
4. The in vitro effects of nicotine and cotinine on prostacyclin and thromboxane biosynthesis.
Chahine R; Calderone A; Navarro-Delmasure C
Prostaglandins Leukot Essent Fatty Acids; 1990 Aug; 40(4):261-6. PubMed ID: 2274564
[TBL] [Abstract][Full Text] [Related]
5. Prostacyclin and thromboxane A2 biosynthesis capacities of heart, arteries and platelets at various stages of experimental atherosclerosis in rabbits.
Gryglewski RJ; Dembińska-Kièć A; Zmuda A; Gryglewska T
Atherosclerosis; 1978 Dec; 31(4):385-94. PubMed ID: 365189
[No Abstract] [Full Text] [Related]
6. Effect of ethanol on vascular prostacyclin (prostaglandin I2) synthesis, platelet aggregation, and platelet thromboxane release.
Mikhailidis DP; Jeremy JY; Barradas MA; Green N; Dandona P
Br Med J (Clin Res Ed); 1983 Nov; 287(6404):1495-8. PubMed ID: 6416473
[TBL] [Abstract][Full Text] [Related]
7. Modulation of Platelet thromboxane A2 and arterial prostacyclin by dietary vitamin E.
Karpen CW; Merola AJ; Trewyn RW; Cornwell DG; Panganamala RV
Prostaglandins; 1981 Oct; 22(4):651-61. PubMed ID: 6798639
[TBL] [Abstract][Full Text] [Related]
8. Regulatory action of cholesterol esters on the eicosanoid metabolism.
Beitz J; Giessler C; Mentz P; Musja G; Bergelson LD
Biomed Biochim Acta; 1984; 43(8-9):S300-3. PubMed ID: 6440545
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of thromboxane A2 biosynthesis in human platelets by burimamide.
Allan G; Eakins KE; Kulkarni PS; Levi R
Br J Pharmacol; 1980; 71(1):157-64. PubMed ID: 6781572
[TBL] [Abstract][Full Text] [Related]
10. [The modification of the biosynthesis and effect of thromboxane A2 and prostacyclin by trapidil (Rocornal)].
Block HU; Heinroth I; Giessler C; Pönicke K; Mentz P; Zehl U; Rettkowski W; Dunemann A; Förster W
Biomed Biochim Acta; 1983; 42(2-3):283-99. PubMed ID: 6411078
[TBL] [Abstract][Full Text] [Related]
11. The effects of dipyridamole on TXA2 formation by horse platelet microsomes.
Katano Y; Imai S
Prostaglandins Leukot Med; 1983 Feb; 10(2):179-85. PubMed ID: 6573686
[TBL] [Abstract][Full Text] [Related]
12. Platelet function and biosynthesis of prostacyclin and thromboxane A2 in whole blood after aspirin administration in human subjects.
Mehta JL; Mehta P; Lopez L; Ostrowski N; Aguila E
J Am Coll Cardiol; 1984 Oct; 4(4):806-11. PubMed ID: 6384329
[TBL] [Abstract][Full Text] [Related]
13. In vivo inhibition of thromboxane biosynthesis by hydralazine.
Greenwald JE; Wong LK; Alexander M; Bianchine JR
Adv Prostaglandin Thromboxane Res; 1980; 6():293-5. PubMed ID: 7386270
[No Abstract] [Full Text] [Related]
14. Role of prostacyclin and thromboxane A2 in ischaemic heart disease.
Neri Serneri GG; Gensini GF; Masotti G; Abbate R; Morettini A; Poggesi L; Fortini A
Adv Exp Med Biol; 1984; 164():175-85. PubMed ID: 6364706
[No Abstract] [Full Text] [Related]
15. Vascular prostaglandin and thromboxane production in a canine model of myocardial ischemia.
Schmitz JM; Apprill PG; Buja LM; Willerson JT; Campbell WB
Circ Res; 1985 Aug; 57(2):223-31. PubMed ID: 3926340
[TBL] [Abstract][Full Text] [Related]
16. Pharmacophore requirements in new series of pyridazinyl alkanoic acids, N-[(pyridazin-2-yl) alkyl] succinyl and glutaryl amides, inhibitors of thromboxane A2 biosynthesis.
Moreau S; Coudert P; Lasserre B; Vallée-Goyet D; Gardette D; Navarro-Delmasure C; Pham Huu Chanh A; Dossou-Gbete V; Couquelet J
Prostaglandins Leukot Essent Fatty Acids; 1997 Jun; 56(6):431-6. PubMed ID: 9223653
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of prostacyclin synthesis by nizofenone.
Yasuda H; Ochi H; Tsumagari T
Biochem Pharmacol; 1984 Sep; 33(17):2707-9. PubMed ID: 6431991
[TBL] [Abstract][Full Text] [Related]
18. Thromboxane A2 biosynthesis inhibitors: synthesis and evaluation of pyrazolotriazinyl alkanoic acids.
Lasserre B; Mavel S; Coudert P; Pham Huu Chanh A; Navarro-Delmasure C; Dossou-Gbete V; Couquelet J
Prostaglandins Leukot Essent Fatty Acids; 1994 Sep; 51(3):157-61. PubMed ID: 7824529
[TBL] [Abstract][Full Text] [Related]
19. Luminal release of prostacyclin and thromboxane A2 by arteries distal to small-caliber prosthetic grafts.
Bush HL; Jakubowski JA; Hong SL; McCabe M; Deykin D; Nabseth DC
Circulation; 1984 Sep; 70(3 Pt 2):I11-5. PubMed ID: 6430592
[TBL] [Abstract][Full Text] [Related]
20. Nicotine inhibits vascular prostacyclin but not platelet thromboxane formation.
Wennmalm A; Alster P
Gen Pharmacol; 1983; 14(1):189-91. PubMed ID: 6402415
[No Abstract] [Full Text] [Related]
[Next] [New Search]
